ArticleLife (Basel, Switzerland)2025
Prediction of Early Diagnosis in Ovarian Cancer Patients Using Machine Learning Approaches with Boruta and Advanced Feature Selection.
Article in Life (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Artificial Intelligence in Gynecologic Oncology: Current Applications, Clinical Challenges, and Future Perspectives.Cureus · 2026Review
- Artificial intelligence (AI) and machine learning (ML) in ovarian cancer: transforming detection, treatment, and prevention.Journal of ovarian research · 2026Review
- Liquid biopsy, multi-cancer early detection, and artificial intelligence: new frontiers in cancer screening from a technological and immunological perspective.Frontiers in immunology · 2026Review
- Investigating key genes and molecular mechanisms of prostate cancer and coronary heart disease through transcriptomics and experimental validation.Translational andrology and urology · 2025Article
- Deep Learning Applications in Clinical Cancer Detection: A Review of Implementation Challenges and Solutions.Mayo Clinic proceedings. Digital health · 2025Review
- Machine Learning Models for Predicting Gynecological Cancers: Advances, Challenges, and Future Directions.Cancers · 2025Review
- Machine learning to evaluate the effects of non-clinical social determinant features in predicting colorectal Cancer mortality in a medically underserved Appalachian population.Scientific reports · 2025Article
- Integrating Clinical and Transcriptomic Profiles Associated with Vitamin D to Enhance Disease-Free Survival in Cervical Cancer Recurrence Using the CatBoost Algorithm.Diagnostics (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesOvarian cancer continues to be one of the most prevalent gynecological cancers diagnosed. Early detection is highly critical for increasing survival chances. This research aims to assess the feature extraction process from various machine learning techniques for better modelling of ovarian cancer and the selection process in ovarian cancer analysis. By eliminating irrelevant features, this approach could guide clinicians towards more accurate results and optimize diagnostic precision.
methodsThis study included both patients with and without ovarian cancer, creating a dataset containing 50 independent variables/features. Eight machine learning algorithms: Random Forest, XGBoost, CatBoost, Decision Tree, K-Nearest Neighbors, Naive Bayes, Gradient Boosting, and Support Vector Machine, were evaluated alongside four feature selection techniques: Boruta, PCA, RFE, and MI. Metrics performance has been evaluated to obtain the best possible combination for diagnosis.
resultsThese results were obtained using these methods with a significantly reduced number of features. Random Forest and CatBoost's performances demonstrated significant differences in contrast to other algorithms (respectively, AUC 0.94% and 0.95%). On the other hand, feature selection methods such as Boruta and RFE consistently reflected higher AUC and accuracy scores than the others.
conclusionsThis study highlights the importance of choosing appropriate machine learning algorithms and feature selection techniques for ovarian cancer diagnosis. Boruta and RFE showed high accuracy. By reducing the number of features from 50 to the most relevant ones, clinicians can make more precise diagnoses, enhance patient outcomes, and reduce unnecessary tests.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.